Alkion BioInnovations is a plant biotech start up, spun out from Imperial College London, building the first industrial in-vitro bioproduction platform for high value active ingredients in the world. The founding team is a pioneer in plant tissue biostimulation technologies with 4 patent families to break plant limits and offer a global access to the critical vaccine adjuvant ingredient QS-21 (Malaria, Tuberculosis, HIV...) and other saponins for which we are setting up an ultra efficient and innovative industrial pilot.
A strong emphasis is placed on sustainability with very low water and energy consumptions, protection of biodiversity and a carbon neutral approach.
website